WT Wealth Management Grows Stock Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)

WT Wealth Management grew its position in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 5.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 56,690 shares of the company’s stock after acquiring an additional 3,030 shares during the quarter. VanEck Pharmaceutical ETF comprises 1.5% of WT Wealth Management’s holdings, making the stock its 18th largest position. WT Wealth Management owned 0.92% of VanEck Pharmaceutical ETF worth $4,891,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Activest Wealth Management acquired a new stake in VanEck Pharmaceutical ETF during the fourth quarter worth $32,000. FMR LLC grew its stake in shares of VanEck Pharmaceutical ETF by 12.5% in the third quarter. FMR LLC now owns 1,905 shares of the company’s stock valued at $181,000 after buying an additional 212 shares in the last quarter. Edge Financial Advisors LLC acquired a new stake in shares of VanEck Pharmaceutical ETF in the third quarter valued at $263,000. Grimes & Company Inc. acquired a new stake in shares of VanEck Pharmaceutical ETF in the fourth quarter valued at $310,000. Finally, Elm3 Financial Group LLC acquired a new stake in shares of VanEck Pharmaceutical ETF in the fourth quarter valued at $324,000.

VanEck Pharmaceutical ETF Trading Down 0.5 %

Shares of NASDAQ PPH opened at $92.97 on Thursday. VanEck Pharmaceutical ETF has a twelve month low of $84.48 and a twelve month high of $99.51. The stock has a fifty day simple moving average of $88.05 and a 200-day simple moving average of $91.46. The stock has a market capitalization of $580.13 million, a PE ratio of 21.04 and a beta of 0.72.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently announced a dividend, which was paid on Monday, December 30th. Investors of record on Friday, December 27th were paid a dividend of $0.411 per share. This is a boost from VanEck Pharmaceutical ETF’s previous dividend of $0.36. The ex-dividend date was Friday, December 27th.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.